Targeting Mitochondrially Unhealthy Obesity to Provide an Alternative Mode of Action for Obesity Therapeutics
- Developing a differentiated mode of action from appetite suppression to generate as good efficacy of dual incretins
- Restoring mitochondrial function with a new mode of action to target obesity
- Targeting energy expenditure form switching to carbohydrate
- Exploring metabolic and obesity drivers